Literature DB >> 31292615

Obesity and risk of infections: results from men and women in the Swedish National March Cohort.

Francesca Ghilotti1,2, Rino Bellocco2,3, Weimin Ye3, Hans-Olov Adami3,4, Ylva Trolle Lagerros1,5.   

Abstract

BACKGROUND: Previous studies have shown an association between body mass index (BMI) and infections, but the literature on type-specific community acquired infections is still limited.
METHODS: We included 39 163 Swedish adults who completed a questionnaire in September 1997 and were followed through record-linkages until December 2016. Information on BMI was self-reported and infections were identified from the Swedish National Patient Register using International Classification of Diseases (ICD), Tenth Revision (ICD-10) codes. We fitted multivariable Cox proportional hazards models for time-to-first-event analysis, and we used extensions of the standard Cox model when repeated events were included.
RESULTS: During a 19-year follow-up 32% of the subjects had at least one infection requiring health care contact, leading to a total of 27 675 events. We found an increased incidence of any infection in obese women [hazard ratio (HR) = 1.22; 95% confidence interval (CI) = 1.12; 1.33] and obese men (HR = 1.25; 95% CI = 1.09; 1.43) compared with normal weight subjects. For specific infections, higher incidences were observed for skin infections in both genders (HR = 1.76; 95% CI = 1.47; 2.12 for obese females and HR = 1.74; 95% CI = 1.33; 2.28 for obese males) and gastrointestinal tract infections (HR = 1.44; 95% CI = 1.19; 1.75), urinary tract infections (HR = 1.30; 95% CI = 1.08; 1.55) and sepsis (HR = 2.09; 95% CI = 1.46; 2.99) in obese females. When accounting for repeated events, estimates similar to the aforementioned ones were found.
CONCLUSIONS: Obesity was associated with an increased risk of infections in both genders. Results from multiple-failure survival analysis were consistent with those from classic Cox models.
© The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Keywords:  Body mass index; epidemiology; infection; obesity; recurrent event; survival analysis

Year:  2019        PMID: 31292615     DOI: 10.1093/ije/dyz129

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  21 in total

1.  Impact of Obesity on Urinary Tract Infections in Korean Adults: Secondary Data Analysis Using Community-Based Cohort Study.

Authors:  Seung Hee Seo; Ihn Sook Jeong; Eun Joo Lee
Journal:  J Korean Acad Nurs       Date:  2021-04       Impact factor: 0.984

Review 2.  Association between body mass index and urinary tract infection: a systematic review and meta-analysis of observational cohort studies.

Authors:  Habeeb Alhabeeb; Saeed Baradwan; Hamed Kord-Varkaneh; Shing Cheng Tan; Teck Yew Low; Osama Alomar; Hany Salem; Ismail Abdulrahman Al-Badawi; Ahmed Abu-Zaid
Journal:  Eat Weight Disord       Date:  2021-01-09       Impact factor: 4.652

Review 3.  Guideline for the Prevention, Diagnosis, and Management of Acute Bacterial Soft Tissue Infections Following Nonsurgical Cosmetic Procedures.

Authors:  Emma Davies; Devan Vaghela; Cormac Convery; Lee Walker; Gillian Murray
Journal:  J Clin Aesthet Dermatol       Date:  2021-09-01

Review 4.  Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back.

Authors:  Viviane Schmidt; Andrew E Hogan; Padraic G Fallon; Christian Schwartz
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

5.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 6.  Extracellular vesicles in obesity and its associated inflammation.

Authors:  Vijay Kumar; Sonia Kiran; Santosh Kumar; Udai P Singh
Journal:  Int Rev Immunol       Date:  2021-08-23       Impact factor: 5.311

7.  Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2.

Authors:  Maximilian Hopf; Christof Kloos; Gunter Wolf; Ulrich Alfons Müller; Nicolle Müller
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

8.  Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.

Authors:  Manjunath P Pai; Mark H Wilcox; Surya Chitra; Paul C McGovern
Journal:  J Antimicrob Chemother       Date:  2021-04-13       Impact factor: 5.790

Review 9.  Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.

Authors:  Andrea De Lorenzo; Vanessa Estato; Hugo C Castro-Faria-Neto; Eduardo Tibirica
Journal:  J Inflamm Res       Date:  2021-05-27

Review 10.  Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics.

Authors:  Andreas Ritter; Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.